Alchemab, Therapeutics

Alchemab Therapeutics signs landmark $415m licensing agreement for ATLX-1282 with Eli Lilly and Company

Published on 08/07/2025 at 18:03 | prnewswire.co.uk

Alchemab Therapeutics United Kingdom United States of America Indiana

View original content:https://www.prnewswire.co.uk/news-releases/alchemab-therapeutics-signs-landmark-415m-licensing-agreement-for-atlx-1282-with-eli-lilly-and-company-302446217.html

en | boerse | 67999966 |